During the music launch of Dhurandhar, the team introduced TV actress Krystle D’Souza as one of the faces of the film’s song Shararat.

Our round-up of biotech financings is led this week by Braveheart Bio, a San Francisco biotech that has launched with $185 million, a lead drug for hypertrophic cardiomyopathy (HCM), and Biogen CEO ...

Aditya Dhar clarified that Dhurandhar was not related to Major Mohit Sharma’s life in response to the Major's brother's ...

As soon as the trailer for Dhurandhar dropped, the internet lit up with speculation about the true story behind Ranveer Singh’s latest role.

Aditya Dhar said that if he does make a biopic on the late braveheart, he would first take his family's consent.

Bristol Myers Squibb currently has the only drug approved specifically for treating obstructive hypertrophic cardiomyopathy, a debilitating disorder that can progress to heart failure. But safety ...

With $185 million in series A funding and an army of experienced leaders in its ranks, Braveheart Bio is setting off to joust with big names in an emerging heart disease drug arena. Backed by ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min It’s one of the largest ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

Curtis Sliwa channels 'Braveheart,' saying he’ll keep battling Zohran Mamdani and his socialist allies regardless of who wins on Tuesday. Trump’s MRI scan raises specter of secrecy in presidential ...

Mel Gibson has hinted that he could film at Scotland’s newest movie studio... if the price is right. The Hollywood icon reacted positively to the news that his iconic Braveheart film has inspired the ...

Jiangsu Hengrui Pharmaceuticals, a Chinese developer of novel drugs, could receive up to US$1.01 billion in milestone payments after granting a US company exclusive rights to develop a heart disease ...